Going Off Active Surveillance: Better Safe Than Sorry
These days, Active Surveillance (AS) seems to be the new best friend for prostate cancer (PCa) patients. Over 40% of newly diagnosed, low-to-favorable intermediate risk patients now begin PCa management on AS. This method defers treatment, but there’s a catch. Patients must be responsible to: Obtain the most thorough portrait of your PCa (multiparametric MRI, keep reading